The Valley Desk

ArticlePharmacoEconomics - openPublished

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
PharmacoEconomics - open
Published
PubMed ID
40266489
PubMed Central ID
PMC12209091
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal